Zephyrus Biosciences - About the company
Zephyrus Biosciences is an acqui-hired company based in Berkeley (United States), founded in 2013 by Josh Molho and Kelly Gardner. It operates as a Tools for single-cell protein analysis.. Zephyrus Biosciences has raised $1.5M in funding from Life Science Angels. The company has 385 active competitors, including 42 funded and 54 that have exited. Its top competitors include companies like Siemens Healthineers, Illumina and Quanterix.
Company Details
Zephyrus is commercializing the scWestern System, a single-cell protein analysis tool for the stem cell & cancer research market. The scWestern System comprises a simple, low-cost hardware lab device, high-margin consumable chips for each experiment, and data analysis software.
- Website
- zephyrusbio.com
- Social
Key Metrics
Founded Year
2013
Location
Berkeley, United States
Stage
Acqui-Hired
Total Funding
$1.5M in 2 rounds
Latest Funding Round
Investors
Ranked
88th among 385 active competitors
Employee Count
1 as on Jul 31, 2026
Similar Companies
Sign up to download Zephyrus Biosciences' company profile
Zephyrus Biosciences's funding and investors
Zephyrus Biosciences has raised a total funding of $1.5M over 2 rounds. Its first funding round was on Sep 10, 2014. Its latest funding round was a Grant (prize money) round on Sep 10, 2014 for $*****. 1 investor participated in its latest round. Zephyrus Biosciences has 9 institutional investors.
Here is the list of recent funding rounds of Zephyrus Biosciences:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 10, 2014 | 1336884 | Grant (prize money) | 1559340 | 4831815 | 5716260 | 1596727 |
Sep 10, 2014 | 5332013 | Seed | 2070885 | 4867198 |
Access funding benchmarks and valuations. Sign up today!View details of Zephyrus Biosciences's funding rounds and investors
Zephyrus Biosciences' founders and board of directors
Founder? Claim ProfileThe founders of Zephyrus Biosciences are Josh Molho and Kelly Gardner.
Here are the details of Zephyrus Biosciences' key team members:
- Josh Molho: CTO & Co-founder (acquired by Bio-Techne) of Zephyrus Biosciences.
- Kelly Gardner: CEO and Co-Founder of Zephyrus Biosciences.
View details of Zephyrus Biosciences's Founder profiles and Board Members
Zephyrus Biosciences' employee count trend
Zephyrus Biosciences has 1 employees as of Jul 26. Here is Zephyrus Biosciences's employee count trend over the years:
Uncover Zephyrus Biosciences' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Zephyrus Biosciences's Competitors and alternates
Top competitors of Zephyrus Biosciences include Siemens Healthineers, Illumina and Quanterix. Here is the list of Top 10 competitors of Zephyrus Biosciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Siemens Healthineers 2017, Forchheim (Germany), Public | Provider of medical imaging laboratory diagnostics and clinical digital solutions | - | 75/100 | |
2nd | Illumina 1993, San Diego (United States), Public | Developer of technologies for analysis of genetic variation and function | $28M | 71/100 | |
3rd | Quanterix 2007, Cambridge (United States), Public | Developer of assay kits for ultra-sensitive biomarker detection | $99.5M | 71/100 | |
4th | BioLife Solutions 1987, Bothell (United States), Acquired | Developer of cell and gene therapies with the integrity of a single cell | - | - | 67/100 |
5th | Biocare Medical 1997, Concord (United States), Acquired | Manufacturer of primary antibodies and instruments for immunohistochemistry applications | $85M | 65/100 | |
6th | Provider of gene sequencing instruments, reagents, equipment, and related products | $1B | 63/100 | ||
7th | Bio-Techne 1981, Minneapolis (United States), Acquired | Developer of biotech reagents, instruments and clinical diagnostic products | - | 59/100 | |
8th |  Abselion 2018, Cambridge (United Kingdom), Series A | Provider of a benchtop instrument for protien research | $12.6M | 59/100 | |
9th | Applied BioCode 2008, Santa Fe Springs (United States), Public | Developer of assay testing kits and instruments for in vitro diagnostics, research, and other industrial applications | $20.3M | 59/100 | |
10th | Bio Rad 1952, Hercules (United States), Public | Portfolio of products and services for life science research and clinical diagnostic markets | - | 58/100 | |
88th | Zephyrus Biosciences 2013, Berkeley (United States), Acqui-Hired | Tools for single-cell protein analysis. | $1.5M | 32/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Zephyrus Biosciences's competitors? Click here to see the top ones
Zephyrus Biosciences's Investments and acquisitions
Zephyrus Biosciences has made no investments or acquisitions yet.
Reports related to Zephyrus Biosciences
Here is the latest report on Zephyrus Biosciences's sector:
News related to Zephyrus Biosciences
•
Stanford StartX & Mission Bay Capital Invest $1.86M in U.C. Berkeley Spin-out for Single Cell Analysis | Business WireBusiness Wire•Sep 10, 2014•Zephyrus Biosciences, NIH, Life Science Angels, Mission Bay Capital and 2 others
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Zephyrus Biosciences
Explore our recently published companies
- Terra Nova IT - San Diego based, 2008 founded, Funding Raised company
- Shareholder Value - Larchmont based, Unfunded company
- Rocks Etc - Sidney based, Unfunded company
- Moving & More CT - Unfunded company
- Galileo Training - Germany based, Unfunded company
- Motion Systems - Eatontown based, 1972 founded, Unfunded company
